Amy Aronovitz, MD
Hollywood, FL 33021
Miramar, FL 33029
Chief, Adult Endocrinology Program
I am board certified in Endocrinology, Diabetes and Metabolism and Internal Medicine. As the Chief of General Endocrinology at Memorial Healthcare System, I treat patients with a variety of conditions, including Type 1 and Type 2 diabetes, thyroid disease, adrenal conditions, calcium and metabolic bone disorders, pituitary disorders and endocrine disorders that complicate pregnancy.
I am a caring and hard-working physician, determined to help provide individualized evidence-based care to my patients. It is their motivation and drive that inspires me to do my best. I like spending time with my patients, developing both short- and long-term relationships with them, and helping make a difference in their lives. Being able to use my experience to help my patients meet their health goals is the best aspect of being a doctor.
Creating the General Endocrinology Department at Memorial Healthcare System is the career accomplishment that makes me proudest.
When I’m not working, I enjoy spending time with my husband and children.
Related Medical Services
- Drexel University College Of Medicine, 2002
- Mount Sinai Hospital Center, 2003, Internal Medicine
- Mount Sinai Hospital Center, 2005, Internal Medicine
- Northwestern University Medical School, 2008, Endocrinology, Diabetes and Metabolism
American Board of Internal Medicine-Internal Medicine
- Endocrine Society
- American Diabetes Association
- 2006-2008 Northwestern University, Chicago, IL
Performed pilot study evaluating the effect of intensive insulin therapy on metabolic parameters in women with gestational diabetes.
Advisor: Boyd E. Metzger, MD
- 2005-2008 Northwestern University, Chicago, IL
Evaluated the effect of betacellulin on cell cycle in both INS-1 cells and murine islets by using flow cytometry, real time PCR, western blots, and BrDU labeling.
Advisor: William Lowe, MD
- 1999 John Hartford Fellowship
University of California, Los Angeles, CA
Compared age-related differences in prescription pattern trends for diabetic men and women with macrovascular complications.
Advisors: Carole Mangione, MD, MPH and
Arlene Brown, MD